基于网络药理学和分子对接技术探索山豆根抗鼻咽癌的作用机制与物质基础
To Explore the Mechanism of Action and Material Basis of Sophora tonkinensis Gagnep in the Treatment of Nasopharyngeal Carcinoma Based on Network Pharmacology and Molecular Docking Technology
摘要: 目的:基于网络药理学和分子对接技术探索山豆根抗鼻咽癌(nasopharyngeal carcinoma, NPC)的作用机制与物质基础。方法:前期研究获取山豆根的活性成分。通过Swiss Target Prediction数据库筛选出山豆根化学成分的潜在作用靶点;GeneCards、OMIM、CTD等数据库检索鼻咽癌的潜在基因靶点;使用Venny 2.0.1平台筛选药物与疾病作用的交集靶点;将药物与疾病的交集靶点导入至String平台构建蛋白互作(PPI)网络,将PPI网络导入Cytoscape软件筛选核心靶点,在Cytoscape软件中制作“中药–活性成分–靶点–疾病”网络图筛选核心活性成分。应用DAVID数据库进行GO和KEGG富集分析,预测涉及的生物过程与代谢通路。使用CB-DOCK2对山豆根抗鼻咽癌的核心活性成分及核心靶点进行分子对接。结果:本研究共筛选山豆根抗鼻咽癌的31个有效活性成分以及51个交集靶点,其中核心活性成分主要包括葛根素、大豆苷、白蜡树素等;核心靶点主要包括MMP9、肿瘤坏死因子(TNF-α)、MMP1、MMP2、IL2等。GO分析主要涉及单碳代谢过程、兴奋性突触后电位、单原子离子跨膜转运等生物过程,KEGG分析主要富集在氮代谢信号通路、炎症性肠病信号通路、膀胱癌信号通路等信号通路。分子对接结果显示核心靶点与对应的活性成分具有良好的结合能力。结论:应用网络药理学和分子对接技术预测山豆根抗鼻咽癌的作用机制以及物质基础,为其进一步研究提供新的思路与线索。
Abstract: Objective: To explore the mechanism of action and material basis of Sophora tonkinensis Gagnep in the treatment of nasopharyngeal carcinoma based on network pharmacology and molecular docking technology. Method: Preliminary research was conducted to identify the active components of Sophora tonkinensis Gagnep. The Swiss Target Prediction database was utilized to screen for potential targets of the chemical constituents of Sophora tonkinensis Gagnep. GeneCards, OMIM, CTD, and other databases were searched to identify potential gene targets for nasopharyngeal carcinoma. The Venny 2.0.1 platform was employed to filter the intersection of drug and disease targets. The intersection targets were imported into the String platform to construct a protein-protein interaction (PPI) network, which was then imported into Cytoscape software to identify core targets and create a “Chinese medicine-active ingredient-targets-disease” network to filter core active ingredients. The DAVID database was applied for GO and KEGG enrichment analysis to predict the biological processes and metabolic pathways involved. CB-DOCK2 was used for molecular docking of the core active ingredients and core targets of Sophora tonkinensis Gagnep against nasopharyngeal carcinoma. Result: This study screened 31 effective active ingredients and 51 intersecting targets of Sophora tonkinensis Gagnep for anti nasopharyngeal carcinoma, among which the core active ingredients mainly include puerarin, daidzein, and dimethylfraxetin; The core targets mainly include MMP9, tumor necrosis factor alpha (TNF-α), MMP1, MMP2, IL2, etc. GO analysis mainly involves a single carbon metabolism process, excitatory postsynaptic potential, monoatomic ion transmembrane transport and other biological processes. KEGG analysis mainly concentrates on the nitrogen metabolism signal pathway, inflammatory bowel disease signal pathway, bladder cancer signal pathway and other signal pathways. The molecular docking results showed that the core target had good binding ability with the corresponding active ingredient. Conclusion: The application of network pharmacology and molecular docking technology to predict the mechanism of action and material basis of the anti nasopharyngeal carcinoma effect of Sophora tonkinensis Gagnep provides new ideas and clues for further research.
文章引用:唐文雅, 魏明星, 李煦照, 张帅男. 基于网络药理学和分子对接技术探索山豆根抗鼻咽癌的作用机制与物质基础[J]. 生物医学, 2025, 15(1): 102-110. https://doi.org/10.12677/hjbm.2025.151011

参考文献

[1] 陈晓钟, 黄爽. 鼻咽癌的治疗进展[J]. 浙江医学, 2021, 43(2): 129-133.
[2] 何文龙, 吕炎, 胡云扬, 等. 放射联合药物治疗鼻咽癌的现状[J]. 实用癌症杂志, 2019, 34(2): 346-348.
[3] 马慧敏, 蓝玉宏, 杨清绪, 等. 同期放化疗治疗鼻咽癌肿瘤残留与预后的关系[J]. 中国医药指南, 2009, 7(8): 183-184.
[4] 陈思睿, 吴天鸿, 刘洁,等. 基于网络药理学、分子对接、实验研究探讨白屈菜治疗鼻咽癌的物质基础及潜在机制[J]. 湖南中医药大学学报, 2024, 44(2): 278-287.
[5] 南俊伶, 王超众, 闫广利, 等. 山豆根抗鼻咽癌活性成分的筛选[J]. 中国药房, 2022, 33(11): 1320-1323, 1329.
[6] 张胜利, 王超众, 闫广利, 等. 山豆根抗肿瘤活性成分及其作用机制研究进展[J]. 中草药, 2023, 54(20): 6844-6855.
[7] 王洁琼, 郭知鑫, 何穗穗, 等. 基于网络药理学和分子对接探讨三七治疗肝纤维化的作用机制[J]. 山东化工, 2024, 53(19): 27-31, 35.
[8] 黄晴, 施春燕. 基于网络药理学研究白芍治疗肝纤维化的作用机制[J]. 药学实践与服务, 2023, 41(8): 485-491.
[9] 龙远雄, 徐寅, 邓桂明. 基于网络药理学与分子对接技术探讨白花蛇舌草治疗鼻咽癌的作用机制[J]. 中南医学科学杂志, 2022, 50(5): 647-651.
[10] Guo, R., Mao, Y., Tang, L., Chen, L., Sun, Y. and Ma, J. (2019) The Evolution of Nasopharyngeal Carcinoma Staging. The British Journal of Radiology, 92, Article ID: 20190244. [Google Scholar] [CrossRef] [PubMed]
[11] Ng, W.T., Corry, J., Langendijk, J.A., Lee, A.W.M., Mäkitie, A., Mendenhall, W.M., et al. (2020) Current Management of Stage IV Nasopharyngeal Carcinoma without Distant Metastasis. Cancer Treatment Reviews, 85, Article ID: 101995. [Google Scholar] [CrossRef] [PubMed]
[12] 王兵, 侯炜. 中医辨治鼻咽癌的几点认识[J]. 世界中西医结合杂志, 2013, 8(1): 89-91.
[13] 张鑫淼, 宋爱英. 中医药诱导铁死亡在鼻咽癌中的研究进展[J]. 临床医学进展, 2024, 14(5): 2647-2652.
[14] 邓晰文. 葛根素抑制鼻咽癌CNE1细胞增殖的机制研究[D]: [硕士学位论文]. 百色: 右江民族医学院, 2023.
[15] Shao, W., Wang, W., Xiong, X., Cao, C., Yan, T.D., Chen, G., et al. (2011) Prognostic Impact of MMP‐2 and MMP‐9 Expression in Pathologic Stage IA Non‐Small Cell Lung Cancer. Journal of Surgical Oncology, 104, 841-846. [Google Scholar] [CrossRef] [PubMed]
[16] Wong, K.C.W., Hui, E.P., Lo, K., Lam, W.K.J., Johnson, D., Li, L., et al. (2021) Nasopharyngeal Carcinoma: An Evolving Paradigm. Nature Reviews Clinical Oncology, 18, 679-695. [Google Scholar] [CrossRef] [PubMed]
[17] 黄武, 孟易禹, 张丽娜. miR-155通过调节ETS1促进鼻咽癌细胞侵袭转移能力的研究[J]. 实用药物与临床, 2023, 26(10): 872-877.
[18] Zhou, G., Zhai, Y., Cui, Y., Qiu, W., Yang, H., Zhang, X., et al. (2007) Functional Polymorphisms and Haplotypes in the Promoter of the MMP2 Gene Are Associated with Risk of Nasopharyngeal Carcinoma. Human Mutation, 28, 1091-1097. [Google Scholar] [CrossRef] [PubMed]
[19] 吴华杰, 屠德桢, 李磊, 等. 白藜芦醇对鼻咽癌转移能力的影响及其分子机制[J]. 昆明医科大学学报, 2023, 44(2): 14-22.
[20] Zhou, M., Qin, S., Chu, Y., et al. (2014) Immunolocalization of MMP-2 and MMP-9 in Human Rheumatoid Synovium. International Journal of Clinical and Experimental Pathology, 7, 3048-56.
[21] Lv, Y., Zhao, X., Zhu, L., Li, S., Xiao, Q., He, W., et al. (2018) Targeting Intracellular MMPs Efficiently Inhibits Tumor Metastasis and Angiogenesis. Theranostics, 8, 2830-2845. [Google Scholar] [CrossRef] [PubMed]
[22] Alrehaili, A.A., Gharib, A.F., Karam, R.A., Alhakami, R.A., El Sawy, W.H. and Abd Elrahman, T.M. (2019) Clinical Significance of Plasma MMP‐2 and MMP‐9 Levels as Biomarkers for Tumor Expression in Breast Cancer Patients in Egypt. Molecular Biology Reports, 47, 1153-1160. [Google Scholar] [CrossRef] [PubMed]
[23] Chang, H., Chen, P., Yang, S., Sun, Y., Wu, S., Hung, T., et al. (2011) Silibinin Inhibits the Invasion and Migration of Renal Carcinoma 786‐O Cells in Vitro, Inhibits the Growth of Xenografts in Vivo and Enhances Chemosensitivity to 5‐fluorouracil and Paclitaxel. Molecular Carcinogenesis, 50, 811-823. [Google Scholar] [CrossRef] [PubMed]
[24] Webb, A.H., Gao, B.T., Goldsmith, Z.K., Irvine, A.S., Saleh, N., Lee, R.P., et al. (2017) Inhibition of MMP-2 and MMP-9 Decreases Cellular Migration, and Angiogenesis in in Vitro Models of Retinoblastoma. BMC Cancer, 17, Article No. 434. [Google Scholar] [CrossRef] [PubMed]
[25] Liu, Z., Li, L., Yang, Z., Luo, W., Li, X., Yang, H., et al. (2010) Increased Expression of MMP9 Is Correlated with Poor Prognosis of Nasopharyngeal Carcinoma. BMC Cancer, 10, Article No. 270. [Google Scholar] [CrossRef] [PubMed]
[26] Wang, D., Wu, C., Liu, D., Zhang, L., Long, G., Hu, G., et al. (2019) Ginsenoside Rg3 Inhibits Migration and Invasion of Nasopharyngeal Carcinoma Cells and Suppresses Epithelial Mesenchymal Transition. BioMed Research International, 2019, Article ID: 8407683. [Google Scholar] [CrossRef] [PubMed]
[27] Funayama, H., Ishikawa, S., Kubo, N., Katayama, T., Yasu, T., Saito, M., et al. (2004) Increases in Interleukin-6 and Matrix Metalloproteinase-9 in the Infarct-Related Coronary Artery of Acute Myocardial Infarction. Circulation Journal, 68, 451-454. [Google Scholar] [CrossRef] [PubMed]
[28] Sapkota, D., Bruland, O., Costea, D.E., Haugen, H., Vasstrand, E.N. and Ibrahim, S.O. (2011) S100A14 Regulates the Invasive Potential of Oral Squamous Cell Carcinoma Derived Cell-Lines in Vitro by Modulating Expression of Matrix Metalloproteinases, MMP1 and Mmp9. European Journal of Cancer, 47, 600-610. [Google Scholar] [CrossRef] [PubMed]
[29] 黄仕思, 梁倩影, 许振胜, 等. MMP20在鼻咽癌中表达及与预后关联性分析[J]. 中国热带医学, 2020, 20(9): 814-817, 821.
[30] 王海妮, 陈安青. 血清IFN-γ、IL-2、EGF预测鼻咽癌患者放疗敏感性和预后的相关性分析[J]. 临床输血与检验, 2020, 22(3): 300-304.
[31] 周美秀, 涂建仁. 鼻咽癌外周血IL-2、IL-10水平与其放化疗敏感性的相关性分析[J]. 实用癌症杂志, 2017, 32(4): 598-602.
[32] 任亮, 顾涛, 徐洁洁. 鼻咽癌患者放疗前后血清SE-cad、IL-2、SIL-2R和TNF-α检测的临床意义[J]. 放射免疫学杂志, 2006, 19(5): 373-375.
[33] 高翠云, 樊湘珍, 王瑞雪, 等. 基于网络药理学探讨鹅不食草治疗鼻咽癌的作用机制[J]. 湖南中医杂志, 2024, 40(5): 156-164.
[34] Propper, D.J. and Balkwill, F.R. (2022) Harnessing Cytokines and Chemokines for Cancer Therapy. Nature Reviews Clinical Oncology, 19, 237-253. [Google Scholar] [CrossRef] [PubMed]
[35] 史鹏帅, 边宇. 鼻咽癌患者血清肿瘤坏死因子-α和白细胞介素-17表达水平及其相关性[J]. 中国老年学杂志, 2023, 43(8): 1823-1826.